Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
8.24
+0.24 (3.00%)
Oct 8, 2025, 2:34 PM EDT - Market open
Bicycle Therapeutics Market Cap
Bicycle Therapeutics has a market cap or net worth of $571.09 million as of October 8, 2025. Its market cap has decreased by -67.54% in one year.
Market Cap
571.09M
Enterprise Value
-132.77M
1-Year Change
-67.54%
Ranking
Category
Stock Price
$8.24
Market Cap Chart
Since May 23, 2019, Bicycle Therapeutics's market cap has increased from $212.36M to $571.09M, an increase of 168.93%. That is a compound annual growth rate of 16.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 570.39M | -40.99% |
| Dec 31, 2024 | 966.64M | 26.03% |
| Dec 29, 2023 | 766.98M | -12.72% |
| Dec 30, 2022 | 878.81M | -50.89% |
| Dec 31, 2021 | 1.79B | 367.96% |
| Dec 31, 2020 | 382.42M | 126.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 766.67B |
| Johnson & Johnson | 455.27B |
| AbbVie | 409.05B |
| UnitedHealth Group | 335.73B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.53B |